Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYBB |
| Upstream (Parents) |
|---|
| (<<) HCLS1 → CYBB |
| (<<) HLA-DQA2///HLA-DQA1 → CYBB |
| Downstream (Children) |
|---|
| CYBB → TYMP (>>) |
| CYBB → FLI1///EWSR1 (>>) |
| CYBB → ACACA (>>) |
| CYBB → HLA-DMB (>>) |
| CYBB → BTK (>>) |
| CYBB → TRIM22 (>>) |
| CYBB → MSN (>>) |
| CYBB → SGK1 (>>) |
| CYBB → LPAR6 (>>) |
| CYBB → CD74 (>>) |
| CYBB → TNFAIP2 (>>) |
| CYBB → IL10RA (>>) |
| CYBB → CLEC4A (>>) |
| CYBB → PTGFR (>>) |
| CYBB → HLA-DQA2///HLA-DQA1 (>>) |
| CYBB → HLA-DPB1 (>>) |
| CYBB → HLA-DRA (>>) |
| CYBB → GIMAP4 (>>) |
| CYBB → RGL1 (>>) |
| CYBB → PLA2G7 (>>) |
| CYBB → ICAM1 (>>) |
| CYBB → HLA-DRB1 (>>) |
| CYBB → DOCK2 (>>) |
